Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the disinflationary effects of AI.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | High Ground Investment Management Edgar Allen | 242,842 | $94,455,824 | +10% | 19.8% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing | |
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing | |
| $296.03 | 1,700 | $503,251.00 | 2,921 | 2021-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 380,441 | $147,976,331 | 0.22% | |
| 2. | 351,635 | $136,771,948 | 0.15% | |
| 3. | 329,656 | $128,222,998 | 1.83% | |
| 4. | 140,686 | $54,721,227 | 1.54% | |
| 5. | 98,969 | $38,494,873 | 0.42% |
News See All
Elevance Health (ELV) Nosedives 12% on Disappointing Q2
In its earnings release, Elevance Health, Inc.
Elevance Health Inc. (NYSE:ELV) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Second Quarter Earnings Conference Call.
UBS Lowered Firm's PT on Elevance Health (ELV), Kept a Buy Rating
Elevance Health, Inc. (NYSE:ELV) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 14, UBS analyst AJ Rice lowered the firm’s price target on Elevance Health, Inc.
12 Best 52-Week Low Stocks to Buy According to Analysts
On July 15, the Consumer Price Index data revealed that core inflation increased by 0.2% on the month; however, the annual rate of 2.9% remains within the estimated range.
Bernstein Maintains a Buy on Elevance Health (ELV), Sets a $585 PT
Elevance Health, Inc. (NYSE:ELV) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 19, Bernstein analyst Lance Wilkes maintained a Buy rating on Elevance Health, Inc.
Wells Fargo Maintains a Buy on Elevance Health (ELV), Sets a $478 PT
Elevance Health, Inc.
10 Cheap Large Cap Stocks to Buy According to Hedge Funds
On July 9, Katie Stockton, Fairlead Strategies founder, appeared on CNBC’s ‘Closing Bell Overtime’ to talk about the current market dynamics.
13 Cheap Healthcare Stocks with Huge Upside Potential
On July 8, Kate Moore, Citi Wealth CIO, appeared on CNBC's 'Squawk Box' to talk about the recent rally in equities.
Wells Fargo Maintained a Buy Rating on Elevance Health (ELV), Kept the PT Unchanged
Elevance Health, Inc. (NYSE:ELV) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 18, Wells Fargo analyst Stephen Baxter maintained a Buy rating on Elevance Health, Inc.
Billionaire Hedge Funds
